Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for GoodRx Holdings, Inc. (GDRX : NSDQ)

• Company Description    GoodRx Holdings Inc. provides consumer-focused digital healthcare platform. GoodRx Holdings Inc. is based in Santa Monica, California. Number of Employees: 738

• Price / Volume Information    Yesterday's Closing Price: $3.86 Daily Weekly Monthly 20 Day Moving Average: 6,229,876 shares Shares Outstanding: 347.45 (millions) Market Capitalization: $1,341.16 (millions) Beta: 1.23 52 Week High: $6.52 52 Week Low: $3.31 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -1.78% -3.73% 12 Week -19.42% -24.19% Year To Date -16.99% -27.54%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 2701 OLYMPIC BOULEVARD - SANTA MONICA,CA 90404 USA ph: 855-268-2822 fax: - ir@goodrx.com http://www.goodrx.com

• General Corporate Information    Officers Wendy Barnes - Chief Executive Officer; President and Director Trevor Bezdek - Chairman Christopher McGinnis - Chief Financial Office Romin Nabiey - Chief Accounting Office Christopher Adams - Director Peer Information GoodRx Holdings, Inc. (CHCR) GoodRx Holdings, Inc. (ESRX) GoodRx Holdings, Inc. (MYDP) GoodRx Holdings, Inc. (COR) GoodRx Holdings, Inc. (GBCS) GoodRx Holdings, Inc. (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 38246G108 SIC: 7374 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/04/25 Share - Related Items Shares Outstanding: 347.45 Most Recent Split Date: (:1) Beta: 1.23 Market Capitalization: $1,341.16 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.05 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.20 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: 11.34% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/04/25

• Fundamental Ratios P/E Current FY Estimate: 19.06 Trailing 12 Months: 22.71 PEG Ratio: 1.68 Price Ratios Price/Book: 2.09 Price/Cash Flow: 12.13 Price / Sales: 1.68 EPS Growth vs. Year Ago Period: 150.00% vs. Previous Quarter: 0.00% Sales Growth vs. Year Ago Period: 1.23% vs. Previous Quarter: 0.05% ROE 09/30/25 - - 06/30/25 - 8.86 03/31/25 - 7.85 ROA 09/30/25 - - 06/30/25 - 4.50 03/31/25 - 3.91 Current Ratio 09/30/25 - - 06/30/25 - 4.21 03/31/25 - 5.23 Quick Ratio 09/30/25 - - 06/30/25 - 4.21 03/31/25 - 5.23 Operating Margin 09/30/25 - - 06/30/25 - 7.53 03/31/25 - 6.75 Net Margin 09/30/25 - - 06/30/25 - 4.33 03/31/25 - 3.57 Pre-Tax Margin 09/30/25 - - 06/30/25 - 6.97 03/31/25 - 6.00 Book Value 09/30/25 - - 06/30/25 - 1.85 03/31/25 - 1.83 Inventory Turnover 09/30/25 - - 06/30/25 - - 03/31/25 - - Debt-to-Equity 09/30/25 - - 06/30/25 - 0.75 03/31/25 - 0.74 Debt-to-Capital 09/30/25 - - 06/30/25 - 42.99 03/31/25 - 42.61

Powered by Zacks Investment Research ©